Associate Pathologist, Massachusetts General Hospital, Associate Physician, Massachusetts General Hospital, Associate Professor of Medicine, and of Pathology, Harvard Medical School
Dr. Kradin's career has integrated formal training in pulmonary medicine, anatomic pathology, basic immunology, and psychiatry. Dr. Kradin's primary area of expertise is the immunopathology of lung disease, to which he has made significant contributions in the areas of antigen processing by dendritic cells, and the immunopathogenesis of acute and chronic interstitial lung injury.
Dr. Kradin has contributed articles and texts in areas as diverse as infectious disease, meditation, and psychosomatic medicine. His concomitant practice of medicine and pathology allowed him to develop an NIH-funded clinical trial of the adoptive transfer of autologous tumor-specific activated lymphocytes and interleukin-2 in the treatment of advanced cancers. This was a pioneering study in the effort to "personalize" cancer treatment, and elements of this approach continue to be adopted by oncologists in the treatment of patients with advanced malignant melanoma and renal cell carcinoma.
Read more in Chapter 23, Immunopathology in Keen Minds to Explore the Dark Continents of Disease, a history of Pathology at Massachusetts General Hospital.
55 Fruit Street
Boston, MA 02114-2696